BENKHEDDA Salim

Prof. BENKHEDDA Salim

Cardiology center Mustapha Hospital Algiers FAculty of medecin UNiversity of Algeirs Benyoucef BENKHEDDA
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2017 in European Journal of Preventive Cardiology
Verified
Journal Article
Closed access
NBNabila Soufi Taleb Bendiab
Nabila Soufi Taleb Bendiab
AMAbderrahim Meziane-Tani
Abderrahim Meziane-Tani
SOSouhila Ouabdesselam
Souhila Ouabdesselam
NMNadera Methia
Nadera Methia
SLSamia Latreche
Samia Latreche
BENKHEDDA SalimBENKHEDDA Salim
BENKHEDDA Salim
Early detection of risk factors for left ventricular (LV) dysfunction may be useful in patients with high blood pressure (HBP). Patient from an outpatient HBP clinic underwent a two-dimensional Doppler-coupled echocardiography with determination of LV global longitudinal strain (GLS) by speckle-tracking. Among 200 patients (mean age 61.7 ± 9.7 years), 155 were overweight, 93 had diabetes, 83 had dyslipidemia, and 109 had uncontrolled HBP. LV hypertrophy (LVH) was found in 136 patients (68%), including concentric (n = 106) and eccentric (n = 30) LVH. Diastolic dysfunction patterns were observed in 178 patients (89%), and increased filling pressures were observed in 37 patients (18.5%). GLS ranged from –25% to –11.6% (mean –16.9 ± 3.2%). Low GLS values (>–17%) were found in 91 patients (45.5%), 68 with and 23 without LVH. In univariate analysis, a reduced GLS was associated with HBP lasting for >10 years (odds ratio (OR) = 3.51, 95% confidence interval (CI) 1.73–7.09; p = 0.002), uncontrolled HBP (OR = 3.55, 95% CI 1.96–6.43; p < 0.0001), overweight (OR = 2.01, 95% CI 0.93–4.31; p = 0.0028), diabetes (OR = 2.21, 95% CI 1.25–3.90; p = 0.006), dyslipidemia (OR = 2.16, 95% CI 1.22–3.84; p = 0.008), renal failure (OR = 4.27, 95% CI 1.80–10.10; p = 0.001), an increased Cornell index (OR = 3.70, 95% CI 1.98–6.90; p < 0.0001), concentric LVH (OR = 9.26, 95% CI 2.62–32.73; p = 0.001), remodeling (OR = 8.51, 95% CI 2.18–33.23; p = 0.002), and filling pressures (OR = 7.1, 95% CI 2.9–17.3; p < 0.0001). In multivariable analysis, duration of HBP (p = 0.038), uncontrolled BP (p = 0.006), diabetes (p = 0.023), LVH (p = 0.001), and increased filling pressures (p = 0.003) remained associated with GLS decline. Early impairment of LV function, detected by a reduced GLS, is associated with long-lasting, uncontrolled HBP, overweight, related metabolic changes, and is more pronounced in patients with LVH.

1 November 2007 in Journal Of Hypertension
Verified
Journal Article
Closed access
MTMohamed Temmar
Mohamed Temmar
CLCarlos Labat
Carlos Labat
BENKHEDDA SalimBENKHEDDA Salim
BENKHEDDA Salim
MCMeriem Charifi
Meriem Charifi
FTFrederique Thomas
Frederique Thomas
ABAthanase Benetos
Athanase Benetos
In-Salah is a city-oasis located in the middle of the Algerian Sahara, a desert area whose drinking water has a high sodium content. No cardiovascular epidemiological studies have ever been conducted in this region. A randomized sample of 635 men and 711 women, aged 40–99 years, was studied. Blood pressure measurements, combined with a clinical questionnaire that included educational and socio-economic data, and standard blood samples for the detection of dyslipidemia and diabetes mellitus, were collected. The mean age was 55 ± 12 years. The prevalence of hypertension was 44% and was highly influenced by age, sex, skin colour, educational status, obesity and metabolic parameters. The higher prevalence of hypertension among black individuals was independent of socio-economic and educational levels, and of metabolic parameters. The presence of antihypertensive treatment was three times more frequent in women than in men, and there was no difference according to skin colour. Among treated subjects, 25% were well controlled, and this percentage was similar among both black and white individuals. Epidemiological studies in such an emergent population indicate that hypertension is a major public health problem. The high sodium content in drinking water in this region could play a major role in the development of hypertension.

1 October 2012 in Journal of Adolescent Health
Verified
Journal Article
Closed access
Paolo SalviPaolo Salvi
Paolo Salvi
MRMiriam Revera
Miriam Revera
LJLaure Joly
Laure Joly
GRGeorge Reusz
George Reusz
MIMaurizio Iaia
Maurizio Iaia
MTMohamed Temmar
Mohamed Temmar

1 November 2017 in Archives of Cardiovascular Diseases
Verified
Journal Article
Closed access
OAOmar Aitmokhtar
Omar Aitmokhtar
FPFranck Paganelli
Franck Paganelli
SBSaida Benamara
Saida Benamara
AAAdel Azaza
Adel Azaza
LBLaurent Bonello
Laurent Bonello
BENKHEDDA SalimBENKHEDDA Salim
BENKHEDDA Salim

28 February 2019 in CardioVascular Journal of Africa
Verified
Journal Article
Closed access
ABAli Bedjaoui
Ali Bedjaoui
KAKarima Allal
Karima Allal
MLMohamed Sofiane Lounes
Mohamed Sofiane Lounes
CBChams Eddine Belhadi
Chams Eddine Belhadi
AMAbdelmoumen Mekarnia
Abdelmoumen Mekarnia
BENKHEDDA SalimBENKHEDDA Salim
BENKHEDDA Salim
To test whether aspiration thrombectomy with intracoronary (IC) instead of intravenous (IV) administration of abciximab could reduce the no-reflow phenomenon in patients undergoing primary percutaneous intervention (PCI) for ST-elevation myocardial infarction (STEMI). Despite recanalisation with PCI, failure to restore microvascular flow may affect the prognosis of patients with STEMI. A combination of aspiration thrombectomy with IC abciximab may improve distal perfusion. After aspiration thrombectomy during primary PCI for STEMI, 160 patients were randomly assigned to either an IV or IC abciximab bolus delivered through the aspiration catheter, both followed by a 12-hour IV abciximab infusion. ST-segment resolution ≥ 70% was achieved in 36 of 78 patients with IC versus 30 of 82 patients with IV abciximab (46.1 vs 36.6%, p = 0.368), and partial resolution in 28 of 78 versus 31 of 82 patients (35.9 vs 37.8%, p = 0.368). Postprocedural myocardial blush grade (MBG) 3 was obtained in 62.8 vs 63.4% (p = 0.235) and MBG ≥ 2 in 89.7 vs 81.7% (p = 0.148) of patients given IC and IV abciximab, respectively. There were three deaths in each group (3.8%). Major adverse cardiac events occurred in six of 78 patients given the IC and seven of 82 patients given the IV abciximab bolus (7.6 vs 8.5%, p = 0.410). One stroke occurred in each group, and two patients in the IC and nine in the IV group developed renal failure (2.5 vs 10.9%, p = 0.414). IC versus IV abciximab did not enhance myocardial reperfusion in non-selected patients with STEMI undergoing primary PCI after aspiration thrombectomy had successfully been performed.

NBNABILA TALEB BENDIAB
NABILA TALEB BENDIAB
SOSouhila Ouabdesselam
Souhila Ouabdesselam
LHLatefa Henaoui
Latefa Henaoui
MLMarilucy Lopez-Sublet
Marilucy Lopez-Sublet
JMJean-Jacques Monsuez
Jean-Jacques Monsuez
BENKHEDDA SalimBENKHEDDA Salim
BENKHEDDA Salim
Background: Although the combination of high blood pressure (HBP) and type 2 diabetes (T2DM) increases the risk of left ventricular (LV) dysfunction, the impact of T2DM on LV geometry and subclinical dysfunction in hypertensive patients and normal ejection fraction (EF) has been infrequently evaluated. Methods: Hypertensive patients with or without T2DM underwent cardiac echocardiography coupled with LV global longitudinal strain (GLS) assessment. Results: Among 200 patients with HBP (mean age 61.7 ± 9.7 years) and EF > 55%, 93 had associated T2DM. Patients with T2DM had a higher body mass index (29.9 ± 5.1 kg/m2 vs. 29.3 ± 4.7 kg/m2, p = 0.025), higher BP levels (158 ± 23/95 ± 13 vs. 142 ± 33/87 ± 12 mmHg, p = 0.003), a higher LV mass index (115.8 ± 32.4 vs. 112.0 ± 24.7 g/m2, p = 0.004), and higher relative wall thickness (0.51 ± 0.16 vs. 0.46 ± 0.12, p = 0.0001). They had more frequently concentric remodeling (20.4% vs. 16.8%, p < 0.001), concentric hypertrophy (53.7% vs. 48.6%, p < 0.001), elevated filling pressures (25.8 vs. 12.1%, p = 0.0001), indexed left atrial volumes greater than 28 mL/m2 (17.2 vs. 11.2%, p = 0.001), and a reduced GLS less than −18% (74.2 vs. 47.7%, p < 0.0001). After adjustment for BP and BMI, T2DM remains an independent determinant factor for GLS decline (OR = 2.26, 95% CI 1.11–4.61, p = 0.023). Conclusions: Left ventricular geometry and subclinical LV function as assessed with GLS are more impaired in hypertensive patients with than without T2DM. Preventive approaches to control BMI and risk of T2DM in hypertensive patients should be emphasized.